Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
Clinical trial NCT04804553 · RECRUITING
Trial details
- NCT number
- NCT04804553
- Sponsor
- Amgen
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-17
- Primary completion
- 2028-03-21
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.